Please wait…

Login required

Username or email:

To use this function please log-in
If you haven't got an account on, you have the opportunity to register regist here for free.

add instrument

Sauren Global Opportunities

Sauren Global Opportunities

ISIN LU0106280919 | WKN 930921 | Mnemonic GGW0 | Type fund
20/07/2018 14:16
Bid Ask
This product is subject to quotation restrictions.
Change from Prev. Day 0.00 EUR / 0.00%
Spread absolute / relative 0,00 / 0,00%

Net Asset Value

Previous Day 32.73 EUR Date 20/07/2018

Price Information

Last Price 32.5600
Date / Time 20.07.2018 / 14:16:39
Price -
Volume in euro -
Volume Size -
High 0.000
Low 0.000
52 week High 33.350
52 week Low 30.310
Trading Hours 09:00 - 18:00

Price History

Date Opening Price Closing Price Daily High Daily Low Volume (pcs.)
20/07/2018 32.5500 32.5600 32.5600 32.5500
19/07/2018 32.4500 32.5400 32.5400 32.4400
18/07/2018 32.4700 32.4700 32.4700 32.4700
17/07/2018 32.5300 32.4700 32.5300 32.4600
16/07/2018 32.3600 32.5300 32.5300 32.3600


Management Fee 1.09 %
Custodian Fee -
Capital forming savings possible? no
Savings Plan yes
Distribution Non Distributing

Frankfurt Trading Parameters

Continous Quotation no
Minimum tradeable Unit 1

Funds Category Comparison

Rating for Sauren Global Opportunities

€uro FondsNote 1
Lipper Leaders, 3 years -
Lipper Leaders, 5 years -
Lipper Leaders, 10 years -
Lipper Leaders, overall -


Fundamental Data

WKN 930921
ISIN LU0106280919
Name Sauren Global Opportunities
Investment Company IPConcept (Lux)
Issued in Luxemburg
Issue Date 31/12/1999
Category Dachfonds hauptsächlich Aktienfonds
currency EUR
Volume 201,508,761.89
Depositary Bank DZ PRIVATBANK S.A.
Paying Agent -
Fund Management Eckhard Sauren
Fiscal Year-End 30.06.
Last Update 10/07/2018

Investment policy

invest like Sauren Global Opportunities: Anlageziel ist ein attraktiver Wertzuwachs in Euro. Der Fonds kann sein Vermögen überwiegend in Anteile offener Fonds investieren, die schwerpunktmäßig in Aktien anlegen. Daneben kann das Fondsvermögen in Anteile von Fonds investiert werden, die schwerpunktmäßig in Aktien und Anleihen (Mischfonds), Anleihen, Wandelanleihen, Genusscheinen, Zertifikaten, Immobilien (max. 40%) oder Geldmarktinstrumenten anlegen. Je nach Einschätzung der Marktlage kann das Fondsvermögen auch vollständig (max. 100%) in einem der vorgenannten Fondstypen angelegt werden. Die Investmentgesellschaft kann Edelmetalle sowohl in physischer Form als auch in indirekter Form erwerben. Waren und Rohstoffe dürfen ausschließlich in indirekter Form erworben werden. Darüber hinaus kann der jeweilige Teilfonds bis zu 30% seines Vermögens indirekt in a) Edelmetalle, b) Rohstoffe und c) Waren über Zertifikate ohne derivative Komponente (Delta 1 Zertifikate), Gold Bullion Securities und nicht-richtlinienkonforme Edelmetallfonds investieren, sofern sie als Wertpapiere zu betrachten sind und eine physische Lieferung an den jeweiligen Teilfonds ausgeschlossen ist.

The following Disclaimer and Information has been prepared by Voltabox AG (the “Issuer”) for the purpose of publishing THE securities prospectus by the issuer. Deutsche Boerse AG does not assume any responsibility for the content of the issuer`s Disclaimer and information.


Important Information


The information contained on the following web pages is directed only at persons who are resident of or domiciled in the Federal Republic of Germany (“Germany”) or the Grand Duchy of Luxembourg (“Luxembourg”). The following information does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities. No offer of securities of the Issuer is being, or will be, made to the public outside Germany and Luxembourg. The offer in Germany and Luxembourg is being made solely on the basis of the securities prospectus (including any amendments thereto) which has been approved by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and which has been published on the Issuer’s website. Any investment decision regarding the publicly offered securities of the Issuer should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from the Issuer (Artegastraße 1, 33129 Delbrück, Germany; Tel.: +49 (0)5250 9930-900; Fax: +49 (0)5250 9762-102) and on the Issuer’s website (

The information contained on the following web pages is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America (“United States”), Canada, Australia or Japan. The Issuer’s shares, and the securities offered in the course of the offer, have not been and will not be registered under the US Securities Act of 1933, as amended (“Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Issuer does not intend to register the offer or parts thereof in the United States or make an offer to the public in the United States, Canada, Australia or Japan.

The information contained on the following web pages is not for distribution to persons who are located in the United States, Canada, Australia or Japan or any other jurisdiction where the offer of the securities to the public is not taking place. Any violation of these restrictions may constitute a breach of the securities laws of these countries. The copying, forwarding or other transmission of the content of the following web pages is prohibited.

By clicking the "I AGREE" button below, you warrant that (i) you have read and accepted the foregoing information and restrictions in full and (ii) you are a resident of or domiciled in Germany or Luxembourg, and (iii) you agree not to distribute or forward the information contained on the following web pages to any person who is not a resident of or domiciled in Germany or Luxembourg.


We regret that, due to regulatory restrictions, we are unable to provide you with access to the following web pages.